Form 4: UnitedHealth Group Director Acquires Additional Shares Through Dividend Equivalents

John H. Noseworthy, a director at UnitedHealth Group, acquired 19 shares of common stock through dividend equivalents on vested deferred stock units.

Summary

• On September 24, 2024, John H. Noseworthy, a director of UnitedHealth Group, acquired 19 shares of common stock.
• The acquisition was a result of dividend equivalents paid on vested deferred stock units.
• These dividend equivalents are immediately vested and subject to the same terms as the underlying deferred stock units.
• Following the transaction, Noseworthy directly owns 5,188 shares of UnitedHealth Group common stock.

Sentiment

Score: 5

Explanation: The document is a routine regulatory filing detailing a standard transaction (dividend equivalent reinvestment). It doesn't inherently convey positive or negative sentiment.

Industry Context

Form 4 filings are a routine part of corporate governance, providing transparency into the transactions of company insiders. This transaction reflects dividend equivalents being reinvested into company stock.

Stakeholder Impact

• The transaction has a negligible impact on shareholders as it involves a small number of shares.

Key Dates